Cannabis Pharmaceuticals Market by Brand (Epidiolex, Sativex), Product Type (Ointments & Creams, Solids and Dissolvable Powder & Oil), Indication, Distribution Channel - Global Forecast 2024-2030

Cannabis Pharmaceuticals Market by Brand (Epidiolex, Sativex), Product Type (Ointments & Creams, Solids and Dissolvable Powder & Oil), Indication, Distribution Channel - Global Forecast 2024-2030


The Cannabis Pharmaceuticals Market size was estimated at USD 1.44 billion in 2023 and expected to reach USD 1.71 billion in 2024, at a CAGR 18.75% to reach USD 4.82 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cannabis Pharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cannabis Pharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cannabis Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aphria, Inc., Aurora Cannabis, Inc., Bausch Health Companies, Inc., Botanix Pharmaceuticals, Breath of Life Pharma, Ltd., Cannabis Science, Inc., Cannamedical Pharma GmbH, Canopy Growth Corporation, Cara Therapeutics Inc., CB Therapeutics Inc., Celadon Pharmaceuticals PLC, Corbus Pharmaceuticals Holdings, Inc., Cronos Group Inc. By Altria Group, Green Thumb Industries, Jazz Pharmaceuticals PLC, Medical Marijuana Inc., MGC Pharmaceuticals Limited, Panaxia Pharmaceutical Industries, Pascal Biosciences Inc., PharmaCyte Biotech, Inc., Renew Biopharma, Inc., Teva Pharmaceutical Industries Ltd., Tilray Brands, Inc., and Zynerba Pharmaceuticals, Inc. by Harmony Biosciences.

Market Segmentation & Coverage


This research report categorizes the Cannabis Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

Brand
Epidiolex
Sativex
Product Type
Ointments & Creams
Solids and Dissolvable Powder & Oil
Indication
Arthritis
Cancer
Epilepsy
Migraine
Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cannabis Pharmaceuticals Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cannabis Pharmaceuticals Market?
3. What are the technology trends and regulatory frameworks in the Cannabis Pharmaceuticals Market?
4. What is the market share of the leading vendors in the Cannabis Pharmaceuticals Market?
5. Which modes and strategic moves are suitable for entering the Cannabis Pharmaceuticals Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cannabis Pharmaceuticals Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the legalization of medicinal cannabis worldwide
5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
5.1.2. Restraints
5.1.2.1. High prices associated with medical cannabis
5.1.3. Opportunities
5.1.3.1. Rise in investments in cannabis-based pharmaceuticals
5.1.3.2. Growing availability through online and retail pharmacies
5.1.4. Challenges
5.1.4.1. Strict regulations in legalization of cannabis extract in several countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cannabis Pharmaceuticals Market, by Brand
6.1. Introduction
6.2. Epidiolex
6.3. Sativex
7. Cannabis Pharmaceuticals Market, by Product Type
7.1. Introduction
7.2. Ointments & Creams
7.3. Solids and Dissolvable Powder & Oil
8. Cannabis Pharmaceuticals Market, by Indication
8.1. Introduction
8.2. Arthritis
8.3. Cancer
8.4. Epilepsy
8.5. Migraine
9. Cannabis Pharmaceuticals Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Cannabis Pharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cannabis Pharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cannabis Pharmaceuticals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Aphria, Inc.
14.1.3. Aurora Cannabis, Inc.
14.1.4. Bausch Health Companies, Inc.
14.1.5. Botanix Pharmaceuticals
14.1.6. Breath of Life Pharma, Ltd.
14.1.7. Cannabis Science, Inc.
14.1.8. Cannamedical Pharma GmbH
14.1.9. Canopy Growth Corporation
14.1.10. Cara Therapeutics Inc.
14.1.11. CB Therapeutics Inc.
14.1.12. Celadon Pharmaceuticals PLC
14.1.13. Corbus Pharmaceuticals Holdings, Inc.
14.1.14. Cronos Group Inc. By Altria Group
14.1.15. Green Thumb Industries
14.1.16. Jazz Pharmaceuticals PLC
14.1.17. Medical Marijuana Inc.
14.1.18. MGC Pharmaceuticals Limited
14.1.19. Panaxia Pharmaceutical Industries
14.1.20. Pascal Biosciences Inc.
14.1.21. PharmaCyte Biotech, Inc.
14.1.22. Renew Biopharma, Inc.
14.1.23. Teva Pharmaceutical Industries Ltd.
14.1.24. Tilray Brands, Inc.
14.1.25. Zynerba Pharmaceuticals, Inc. by Harmony Biosciences
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. CANNABIS PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CANNABIS PHARMACEUTICALS MARKET DYNAMICS
FIGURE 7. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2023 VS 2030 (%)
FIGURE 8. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings